In addition, IFC-305, an adenosine derivative, inhibits methylation of the PPARγ promoter and up-regulates PPARγ expression, thereby reducing the risk of radiation-induced intestinal toxicity in colon cancer treatment [100]. Here, PPARG is linked to malignant colon neoplasm.